StemCell Therapy

The 700kHz, 260-element histotripsy ultrasound array transducer used in Prof. Xus lab. Credit: Photo by Marcin Szczepanski/Lead Multimedia Storyteller, Michigan Engineering

A new technique pioneered in rats at the University of Michigan could improve outcomes for cancer and neurological conditions.

Noninvasive sound technology developed at the University of Michigan breaks down liver tumors in rats, kills cancer cells, and spurs the immune system to prevent further spreadan advance that could lead to improved cancer outcomes in humans.

By destroying only 50% to 75% of liver tumor volume, the rats immune systems were able to clear away the rest, with no evidence of recurrence or metastases in more than 80% of the animals.

Even if we dont target the entire tumor, we can still cause the tumor to regress and also reduce the risk of future metastasis, said Zhen Xu, professor of biomedical engineering at U-M and corresponding author of the study in Cancers.

Zhen Xu, Professor of Biomedical Engineering at the University of Michigan works in her office. Dr. Xus research focuses on developing new ultrasound technique for treatment of cancer, cardiovascular diseases, and neurological diseases. She and her colleagues have developed histotripsy, an ultrasound ablation technique via controlled cavitation. Histotripsy is the first image-guided ablation technique that is non-invasive, non-ionizing, and non-thermal. Dr. Xus work spans from basic science, device development, preclinical investigations, to clinical translation of histotripsy. Credit: Photo by Marcin Szczepanski/Lead Multimedia Storyteller, Michigan Engineering

Results also showed the treatment stimulated the rats immune responses, possibly contributing to the eventual regression of the untargeted portion of the tumor and preventing further spread of the cancer.

The treatment, called histotripsy, noninvasively focuses ultrasound waves to mechanically destroy target tissue with millimeter precision. The relatively new technique is currently being used in a human liver cancer trial in the United States and Europe.

In many clinical situations, the entirety of a cancerous tumor cannot be targeted directly in treatments for reasons that include the mass size, location or stage. To investigate the effects of partially destroying tumors with sound, this latest study targeted only a portion of each mass, leaving behind a viable intact tumor. It also allowed the team, including researchers at Michigan Medicine and the Ann Arbor VA Hospital, to show the approachs effectiveness under less than optimal conditions.

Zhen Xu,Professor of Biomedical Engineering at the University of Michigan (left) and Tejaswi Worlikar, Biomedical Engineering PhD student discuss the 700kHz, 260-element histotripsy ultrasound array transducer they use in Prof. Xus lab. Credit: Photo by Marcin Szczepanski/Lead Multimedia Storyteller, Michigan Engineering

Histotripsy is a promising option that can overcome the limitations of currently available ablation modalities and provide safe and effective noninvasive liver tumor ablation, said Tejaswi Worlikar, a doctoral student in biomedical engineering. We hope that our learnings from this study will motivate future preclinical and clinical histotripsy investigations toward the ultimate goal of clinical adoption of histotripsy treatment for liver cancer patients.

Liver cancer ranks among the top 10 causes of cancer related deaths worldwide and in the U.S. Even with multiple treatment options, the prognosis remains poor with five-year survival rates less than 18% in the U.S. The high prevalence of tumor recurrence and metastasis after initial treatment highlights the clinical need for improving outcomes of liver cancer.

Where a typical ultrasound uses sound waves to produce images of the bodys interior, U-M engineers have pioneered the use of those waves for treatment. And their technique works without the harmful side effects of current approaches such as radiation and chemotherapy.

Zhen Xu, Professor of Biomedical Engineering at the University of Michigan (center) and Tejaswi Worlikar, Biomedical Engineering PhD student (right) move the 700kHz, 260-element histotripsy ultrasound array transducer they use in Prof. Xus lab. Credit: Photo by Marcin Szczepanski/Lead Multimedia Storyteller, Michigan Engineering

Our transducer, designed and built at U-M, delivers high amplitude microsecond-length ultrasound pulsesacoustic cavitationto focus on the tumor specifically to break it up, Xu said. Traditional ultrasound devices use lower amplitude pulses for imaging.

The microsecond long pulses from UMs transducer generate microbubbles within the targeted tissuesbubbles that rapidly expand and collapse. These violent but extremely localized mechanical stresses kill cancer cells and break up the tumors structure.

Reference: Impact of Histotripsy on Development of Intrahepatic Metastases in a Rodent Liver Tumor Model by Tejaswi Worlikar, Man Zhang, Anutosh Ganguly, Timothy L. Hall, Jiaqi Shi, Lili Zhao, Fred T. Lee, Mishal Mendiratta-Lala, Clifford S. Cho and Zhen Xu, 22 March 2022, Cancers.DOI: 10.3390/cancers14071612

Since 2001, Xus laboratory at U-M has pioneered the use of histotripsy in the fight against cancer, leading to the clinical trial #HOPE4LIVER sponsored by HistoSonics, a U-M spinoff company. More recently, the groups research has produced promising results on histotripsy treatment of brain therapy and immunotherapy.

The study was supported by grants from the National Institutes of Health, Focused Ultrasound Foundation, VA Merit Review, U-Ms Forbes Institute for Discovery and Michigan Medicine-Peking University Health Sciences Center Joint Institute for Translational and Clinical Research.

Read the original post:
Noninvasive Sound Technology Breaks Down Tumors, Kills Cancer Cells, and Spurs the Immune System - SciTechDaily

This entry was posted on April 26, 2022 at 1:50 am and is filed under Immune System. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed. |